Japan DMF guidelines given by PMDA & Key points:-

The Japan DMF (Drug Master File) guidelines are outlined in the "Guidance for Drug Master Files" published by the Pharmaceuticals and Medical Devices Agency (PMDA). Here are the key points:

1. *Types of DMFs*: Japan accepts Type II (API), Type III (Packaging Materials), and Type IV (Excipients) DMFs.

2. *Submission*: DMFs should be submitted in Japanese, with English summaries.

3. *Format*: Follow the ICH Q7 (API) or ICH Q6A (Excipients) format.

4. *Content*: Include company information, manufacturing process, quality control, analytical methods, stability data, and regulatory compliance information.

5. *API DMF*:

- Manufacturing process and controls

- Quality control and assurance

- Analytical methods and validation

- Stability data

- Regulatory compliance

6. *Packaging Material DMF*:

- Material composition and specifications

- Manufacturing process and controls

- Quality control and assurance

- Regulatory compliance

7. *Excipient DMF*:

- Material composition and specifications

- Manufacturing process and controls

- Quality control and assurance

- Regulatory compliance

8. *Review and Approval*: DMFs are reviewed by the PMDA, and approval is granted if the DMF meets the guidelines.

9. *Maintenance*: DMFs should be updated every 5 years or when significant changes occur.

10. *Confidentiality*: DMF information is treated as confidential.

Please note that these guidelines may be subject to change, and it's always best to consult the PMDA website or contact them directly for the most up-to-date information.